• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用细菌提取物进行固有免疫训练可增强肺部巨噬细胞募集,以预防β冠状病毒感染。

Innate Immune Training with Bacterial Extracts Enhances Lung Macrophage Recruitment to Protect from Betacoronavirus Infection.

机构信息

Department of Internal Medicine II/Cardiology, Medical University of Vienna, Vienna, Austria.

Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria.

出版信息

J Innate Immun. 2022;14(4):293-305. doi: 10.1159/000519699. Epub 2021 Nov 12.

DOI:10.1159/000519699
PMID:34775384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9059017/
Abstract

Training of the innate immune system with orally ingested bacterial extracts was demonstrated to have beneficial effects on infection clearance and disease outcome. The aim of our study was to identify cellular and molecular processes responsible for these immunological benefits. We used a murine coronavirus (MCoV) A59 mouse model treated with the immune activating bacterial extract Broncho-Vaxom (BV) OM-85. Tissue samples were analysed with qPCR, RNA sequencing, histology, and flow cytometry. After BV OM-85 treatment, interstitial macrophages accumulated in lung tissue leading to a faster response of type I interferon (IFN) signalling after MCoV infection resulting in overall lung tissue protection. Moreover, RNA sequencing showed that lung tissue from mice receiving BV OM-85 resembled an intermediate stage between healthy and viral infected lung tissue at day 4, indicating a faster return to normal tissue homoeostasis. The pharmacologic effect was mimicked by adoptively transferring naive lung macrophages into lungs from recipient mice before virus infection. The beneficial effect of BV OM-85 was abolished when inhibiting initial type I IFN signalling. Overall, our data suggest that BV OM-85 enhances lung macrophages allowing for a faster IFN response towards a viral challenge as part of the oral-induced innate immune system training.

摘要

经口服摄入细菌提取物训练先天免疫系统已被证明对清除感染和改善疾病预后具有有益效果。我们研究的目的是确定负责这些免疫益处的细胞和分子过程。我们使用了一种感染鼠冠状病毒(MCoV)A59 的小鼠模型,并用免疫激活细菌提取物 Broncho-Vaxom(BV)OM-85 进行处理。使用 qPCR、RNA 测序、组织学和流式细胞术分析组织样本。在接受 BV OM-85 治疗后,间质性巨噬细胞在肺部组织中积聚,导致在 MCoV 感染后更快地响应 I 型干扰素(IFN)信号,从而对肺部组织整体起到保护作用。此外,RNA 测序显示,接受 BV OM-85 治疗的小鼠肺部组织在第 4 天与健康和病毒感染肺部组织之间呈现中间阶段,表明更快地恢复到正常组织稳态。在病毒感染前将幼稚肺巨噬细胞过继转移到受体小鼠的肺部,可以模拟这种药理作用。当抑制初始 I 型 IFN 信号时,BV OM-85 的有益作用被消除。总的来说,我们的数据表明,BV OM-85 增强了肺巨噬细胞,使其能够更快地对病毒挑战产生 IFN 反应,这是口服诱导的先天免疫系统训练的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/f5b5f66385f9/jin-0014-0293-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/9b2a517df5d9/jin-0014-0293-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/1b473cc19449/jin-0014-0293-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/3379caf41e0b/jin-0014-0293-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/a47f33550afc/jin-0014-0293-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/e0dcab38a584/jin-0014-0293-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/8d15878b4d4b/jin-0014-0293-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/f5b5f66385f9/jin-0014-0293-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/9b2a517df5d9/jin-0014-0293-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/1b473cc19449/jin-0014-0293-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/3379caf41e0b/jin-0014-0293-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/a47f33550afc/jin-0014-0293-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/e0dcab38a584/jin-0014-0293-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/8d15878b4d4b/jin-0014-0293-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/9274953/f5b5f66385f9/jin-0014-0293-g07.jpg

相似文献

1
Innate Immune Training with Bacterial Extracts Enhances Lung Macrophage Recruitment to Protect from Betacoronavirus Infection.利用细菌提取物进行固有免疫训练可增强肺部巨噬细胞募集,以预防β冠状病毒感染。
J Innate Immun. 2022;14(4):293-305. doi: 10.1159/000519699. Epub 2021 Nov 12.
2
The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection.细菌提取物 OM-85 BV 可保护小鼠免受流感和沙门氏菌感染。
Int Immunopharmacol. 2010 Sep;10(9):1086-90. doi: 10.1016/j.intimp.2010.06.009. Epub 2010 Jun 11.
3
Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines.泛福舒(OM-85 BV)对gp130结合细胞因子的独特作用。
Thorax. 2000 Aug;55(8):678-84. doi: 10.1136/thorax.55.8.678.
4
Macrophage activation by OM-85 BV.OM-85 BV对巨噬细胞的激活作用。
Respiration. 1992;59 Suppl 3:14-8. doi: 10.1159/000196125.
5
Broncho-Vaxom® (OM-85 BV) soluble components stimulate sinonasal innate immunity.Broncho-Vaxom®(OM-85BV)可溶性成分可刺激鼻-鼻窦固有免疫。
Int Forum Allergy Rhinol. 2019 Apr;9(4):370-377. doi: 10.1002/alr.22276. Epub 2019 Jan 7.
6
In vivo study on the immunomodulating effects of OM-85 BV on survival, inflammatory cell recruitment and bacterial clearance in Klebsiella pneumonia.关于OM-85 BV对肺炎克雷伯菌肺炎的生存、炎症细胞募集和细菌清除的免疫调节作用的体内研究。
Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):559-64. doi: 10.1016/s0192-0561(97)00083-0.
7
Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.支气管疫苗(OM-85 BV)通过C-Fos/血清反应元件诱导白细胞介素6和白细胞介素8表达。
Thorax. 1996 Feb;51(2):150-4. doi: 10.1136/thx.51.2.150.
8
Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies.OM-85 BV对免疫保护机制的刺激作用。体内和体外研究结果综述。
Respiration. 1994;61 Suppl 1:8-15. doi: 10.1159/000196372.
9
Th1-orientated immunological properties of the bacterial extract OM-85-BV.细菌提取物OM-85-BV的Th1型免疫特性
Eur J Med Res. 2005 May 20;10(5):209-17.
10
Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages.细菌提取物(支气管疫苗)对小鼠巨噬细胞代谢和功能活性的刺激作用。
Int J Immunopharmacol. 1989;11(6):637-45. doi: 10.1016/0192-0561(89)90149-5.

引用本文的文献

1
Trained immunity in the lung.肺部的训练有素的免疫
Elife. 2025 Aug 1;14:e104918. doi: 10.7554/eLife.104918.
2
Surface temperature changes indicate disease onset after pulmonary murine corona virus infection, but do not constitute a humane endpoint.体表温度变化表明小鼠感染肺冠状病毒后疾病发作,但不构成人道终点。
Vet Res Commun. 2025 Jun 28;49(4):238. doi: 10.1007/s11259-025-10806-9.
3
Non-Invasive Analyses of Altered Schaedler Flora in C57Bl/6J and Balb/c Mice to Monitor Hygiene Status of a Housing Facility.对C57Bl/6J和Balb/c小鼠中改变的悉生菌群进行无创分析,以监测饲养设施的卫生状况。

本文引用的文献

1
Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.旧疫苗应对新感染:利用先天免疫控制 COVID-19 并预防未来的大流行。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2101718118.
2
Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.单核细胞和巨噬细胞:严重急性呼吸综合征冠状病毒 2 的作用靶点:2019 冠状病毒病免疫麻痹的线索。
J Infect Dis. 2021 Aug 2;224(3):395-406. doi: 10.1093/infdis/jiab044.
3
Trained immunity, tolerance, priming and differentiation: distinct immunological processes.
Animals (Basel). 2025 Jun 11;15(12):1725. doi: 10.3390/ani15121725.
4
Effects of Yeast β-Glucan Supplementation on Calf Intestinal and Respiratory Health.补充酵母β-葡聚糖对犊牛肠道和呼吸道健康的影响。
Animals (Basel). 2025 Mar 30;15(7):997. doi: 10.3390/ani15070997.
5
Long-term sublingual bacterial immunotherapy prevents ear, nose and throat infections: A real-life study.长期舌下细菌免疫疗法可预防耳鼻喉感染:一项真实病例研究。
SAGE Open Med. 2025 Jan 24;13:20503121241309514. doi: 10.1177/20503121241309514. eCollection 2025.
6
European Respiratory Society Research Seminar on Preventing Pediatric Asthma.欧洲呼吸学会预防儿童哮喘研究研讨会
Pediatr Pulmonol. 2025 Jan;60(1):e27401. doi: 10.1002/ppul.27401. Epub 2024 Dec 3.
7
Diverging patterns in innate immunity against respiratory viruses during a lifetime: lessons from the young and the old.一生中针对呼吸道病毒的先天免疫的不同模式:从年轻人和老年人中得到的教训。
Eur Respir Rev. 2024 Jun 12;33(172). doi: 10.1183/16000617.0266-2023. Print 2024 Apr.
8
Broncho-Vaxom Attenuates Lipopolysaccharide-Induced Inflammation in a Mouse Model of Acute Lung Injury.Broncho-Vaxom 减轻脂多糖诱导的急性肺损伤小鼠模型中的炎症反应。
Int J Mol Sci. 2024 Jun 28;25(13):7135. doi: 10.3390/ijms25137135.
9
Engineered Probiotic-Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity.基于工程益生菌的个体化癌症疫苗通过启动训练免疫增强抗肿瘤免疫。
Adv Sci (Weinh). 2024 Jan;11(3):e2305081. doi: 10.1002/advs.202305081. Epub 2023 Nov 27.
10
Emerging role for interferons in respiratory viral infections and childhood asthma.干扰素在呼吸道病毒感染和儿童哮喘中的新作用。
Front Immunol. 2023 Feb 21;14:1109001. doi: 10.3389/fimmu.2023.1109001. eCollection 2023.
训练免疫、耐受、致敏和分化:不同的免疫过程。
Nat Immunol. 2021 Jan;22(1):2-6. doi: 10.1038/s41590-020-00845-6.
4
Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement.复发性呼吸道感染儿童新发呼吸道感染的预防:专家共识声明
Microorganisms. 2020 Nov 17;8(11):1810. doi: 10.3390/microorganisms8111810.
5
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.冠状病毒:先天免疫、炎症小体激活、炎症细胞死亡和细胞因子。
Trends Immunol. 2020 Dec;41(12):1083-1099. doi: 10.1016/j.it.2020.10.005. Epub 2020 Oct 15.
6
Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.《老鼠和男人:冠状病毒 MHV 及其小鼠模型作为一种转化方法来理解 SARS-CoV-2》。
Viruses. 2020 Aug 12;12(8):880. doi: 10.3390/v12080880.
7
Longitudinal analyses reveal immunological misfiring in severe COVID-19.纵向分析揭示了重症 COVID-19 中的免疫失调。
Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27.
8
Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85.上皮功能障碍、呼吸道感染和哮喘:免疫调节的重要性。聚焦 OM-85。
Expert Rev Respir Med. 2020 Oct;14(10):1019-1026. doi: 10.1080/17476348.2020.1793673. Epub 2020 Jul 15.
9
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.新型冠状病毒肺炎中(微)血栓形成的新威胁及其治疗意义。
Circ Res. 2020 Jul 31;127(4):571-587. doi: 10.1161/CIRCRESAHA.120.317447. Epub 2020 Jun 26.
10
The many faces of the anti-COVID immune response.抗新冠病毒免疫反应的多面性。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200678.